[Skip to Navigation]
Sign In
Invited Commentary
March 31, 2021

Who Should Undergo Transplant for Metastatic Colorectal Cancer?A Shift in Treatment Paradigm

Author Affiliations
  • 1City of Hope Medical Center, Duarte, California
JAMA Surg. 2021;156(6):557. doi:10.1001/jamasurg.2021.0268

The outcomes of transplant for metastatic disease in the early days of liver transplantation were dismal.1 Early recurrence was common and 3-year survival was unusual. These results, coupled with a shortage of cadaveric organs for transplant, led to an abandonment of transplant as a treatment option for colorectal liver metastases. In this issue of JAMA Surgery, Dueland and colleagues2 present data that see this treatment in a new light.

Add or change institution